Introduction
Epilepsy surgery is a well-accepted treatment option for selected patients with antiepileptic drug (AED)-resistant epilepsies. Among epilepsy surgery series, resections of the frontal, parietal and occipital neocortex together accounted for only onethird, whereas two-thirds of resections involved the temporal lobe. 1 This difference is largely due to the exclusion of many patients with extratemporal epilepsies from resective surgery because of the difficulties encountered in defining the epileptogenic zone and more frequent overlap of the epileptogenic zone with functional cortical areas. 1,2 While two-thirds of patients undergoing temporal lobe resections become seizure-free, only less than half of patients undergoing extratemporal resections achieve seizure freedom, that also at the expense of significantly more neurological morbidity. [3] [4] [5] Refinements in magnetic resonance imaging (MRI), digital video-EEG, ictal single photon emission computed tomography (SPECT), interictal positron emission tomography (PET) and magnetoencephalography (MEG) provide valuable non-invasive information helpful to localize epileptogenic zones, thereby minimizing the need for invasive monitoring. [6] [7] [8] Functional MRI (fMRI) can define eloquent cortical areas to a level of accuracy comparable to that provided by cortical stimulation and mapping through intracranial electrodes. 9, 10 All these technological developments have resulted in recent years in a steady increase in extratemporal resective epilepsy surgeries with improved seizurefree outcome and decreased neurological morbidity.
referred to hereafter as resource-poor countries) lack the full range of technologies usually available in centers in the upper-middle income and high income countries 13 (collectively referred to hereafter as resource-rich countries) to perform presurgical evaluation. 14, 15 Moreover, in most of the resource-poor countries, health insurance does not cover the cost of epilepsy care. The PET, SPECT, fMRI and MEG are seldom available in resource-poor countries, and the cost of invasive monitoring prohibits its use except in a small number of affluent patients. In such a scenario, selection of ideal extratemporal resective epilepsy surgical candidates using locally available technology becomes a real challenge. Seldom does an epilepsy surgery center reports the proportion of patients who were excluded from surgery following presurgical evaluation and reasons for their exclusion. To our knowledge, no study has systematically inquired the reasons for exclusion of patients specifically with respect to extratemporal resective epilepsy surgery from a single epilepsy center. It might be presumed that because of the better availability of advanced presurgical evaluation technologies and their accessibility and affordability, larger proportion of patients in resource-rich countries would get selected for surgery when compared to those from resource-poor countries.
The information regarding the reasons for exclusion of patients from extratemporal resective epilepsy surgery will be helpful, especially to epilepsy surgery centers in resource-poor countries, to select ideal candidates for surgery using locally available investigative facilities and expertise. Understanding when not to operate because of the need for further evaluation is as, or perhaps even more, important as knowing which patients may benefit from surgery. In order to address this issue, we audited our presurgical evaluation strategy and inquired the reasons for exclusion from extratemporal resective epilepsy surgery in a well-established center in southern India.
Materials and methods

Study setting and subjects
From the prospective database maintained at the R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, southern India, we reviewed the data of all consecutive patients who had undergone presurgical evaluation for AED-resistant extratemporal focal epilepsies from January 2005 through December 2008. Patients with AED-resistant epilepsies are referred to this center by neurologists, physicians and general practitioners from all over India. This center has undertaken more than 1200 epilepsy surgeries during the last 15 years. 
Presurgical evaluation and selection for surgery
Our standard presurgical evaluation protocol included a detailed clinical history and examination, long-term video-EEG monitoring, 1.5 T magnetic resonance imaging (MRI) and neuropsychological evaluation. [16] [17] [18] Those especially relevant to evaluation of patients with extratemporal epilepsies were detailed in a recent publication. 2 The diagnosis of extratemporal focal epilepsies was based on the presurgical evaluation data indicating origin of seizures from frontal, parietal and occipital lobes. We classified the interictal epileptiform discharges (IEDs) in the long-term EEG as concordant, if !75% of the IEDs corresponded to the presumed site of seizure origin (based on seizure semiology, MRI abnormality, if present, and/or area resected) and discordant (contralateral, bilateral independent, multifocal or generalized). The scalprecorded ictal EEG activity was categorized as localized to the presumed lobe of seizure origin, lateralized to the presumed hemisphere of seizure origin, and diffuse (uncertain hemispheric origin). In addition to our routine MRI protocol, 17 we undertook additional three-dimensional fluid attenuation inversion recovery (3D-FLAIR) and susceptibility weighted imaging (SWI) MRI sequences, 19 and functional MRI (fMRI) for motor and language functions in patients with lesions at or close to motor or language areas. We have described our fMRI protocol in detail in a recent publication. 10 Selected patients were subjected to 3 T MRI and surface coil imaging, when the index of suspicion of a lesion was high in 1.5 T MRI. While interpreting the MRI, the neuroradiologist (CK) paid special attention to detect any abnormality in the suspected lobe/hemisphere of seizure onset based on the clinical features and long-term video-EEG monitoring findings. The SPECT became available to our patients from 2004 and PET from 2007. We undertake ictal and interictal SPECT, but do not subtract between them or co-register to MRI. MEG was not available at our center during the study period. We selected patients for resective surgery after a thorough discussion in the multidisciplinary patient management conference based upon the concordance of clinical-EEG-imaging findings. 16 Nine patients with discordant or nonlocalizing data underwent invasive EEG monitoring before being selected for surgery.
Economic issues
In India, health insurance does not cover the cost of epilepsy care. We charge patients according to their income. While rich patients bear the total cost, the poorest receive noninvasive presurgical evaluation and surgery free of cost. However, the cost of advanced investigations such as SPECT, PET and invasive monitoring will have to be borne by all patients, irrespective of their income status. The per capita domestic product of the geographical region in Indian Rupees (INR) is 39,300 (US dollar [$] 980). 20 In a previous study, we have computed that while the mean combined cost of noninvasive presurgical evaluation, uncomplicated extratemporal resective surgery and hospital stay was INR 60,000 ($1500), invasive monitoring escalated the mean cost to INR 137,000 ($3400). 2 
Results
Patient groups
During the study period, 285 (193 males, 92 females) patients with extratemporal focal epilepsies underwent presurgical evaluation. Their mean age at the time of evaluation was 19.4 (range 1.4-48) years, and the mean age of seizure onset was 7.7 years (neonatal period -31 years). The mean duration of epilepsy prior to surgery was 11.6 years. Only 71 (24.9%) of them underwent resective surgery; the remaining 214 (75.1%) patients could not be selected for surgery. They formed the 'surgical' and 'non-surgical' groups of patients, respectively.
Intergroup comparisons
Clinical characteristics
We have compared by univariate analysis the clinical features of the surgical and non-surgical groups of patients in Table 1 . Compared to non-surgical group, significantly fewer patients in the surgical group had secondarily generalized seizures (46.3% vs. 11.3%, P < 0.0005). By contrast, clustering of seizures (defined as !3 seizures occurring in succession or in isolation within 24 h) (94.4% vs. 77.1%, P = 0.001) and presence of preoperative focal neurological deficits (29.2% vs. 13.6%, P = 0.002) were encountered in significantly more patients in the surgical group compared to non-surgical group.
Video-EEG findings
We have compared the long-term video-EEG data in Table 2 . The IEDs were concordant to the presumed site of seizure origin in 59% of the surgical group of patients, while they were discordant to the site of presumed seizure origin in 84% of the nonsurgical group of patients (P < 0.0005). Compared to nonsurgical group, patients in the surgical cohort had more frequent lateralized ictal onset (57.7% vs. 39.7%, P < 0.0005) and less frequent uncertain ictal onset (12.7% vs. 42.5%, P < 0.0005).
MRI findings
We have compared the MRI findings between the surgical and non-surgical groups of patients in Table 3 . While all the patients in the surgical group had MRI demonstrable lesions, MRI was normal in 122 (57%) non-surgical group of patients. Gliosis and malformations of cortical development were the most common lesions in both the groups. While the malformations of cortical development seen in the surgical group comprised only focal cortical dysplasia, non-surgical group, in addition had other difficult to operate malformations such as closed lip schizencephaly, perisylvian polymicrogyria, bilateral posterior head lissencephaly and posterior quadrant hemimegalencephaly. The presence of well circumscribed lesions like focal cortical dysplasia, focal gliosis, low-grade neoplasm, vascular malformation and focal calcifications favored surgical selection. Gliosis was bilateral in 58% of the non-surgical cohort as compared to 11% in the surgical cohort (P < 0.0005). Similarly, 10 (43.5%) patients with poorly defined (architectural) dysplasia and 13 (39.1%) patients with encroachment of the dysplasia to eloquent area were excluded from surgery.
Other noninvasive investigations
During our study period, 26 patients underwent SPECT, 15 of them had normal MRI and it guided us to proceed with surgery in only 2 patients. Out of our 64 patients who underwent PET (40 of them had normal MRI), in only 9 patients PET provided information helpful to proceed with either direct surgery and/or invasive monitoring. In the rest, PET showed either diffuse changes or was essentially normal.
Seizure outcome
Fifty-two out of 71 (73.2%) patients of the surgical group were seizure-free during the mean postoperative follow-up period of 2.6 (range 1-5) years. Fifty-eight patients in the non-surgical group (27%) were lost to subsequent follow-up. Out of the remaining 156 patients of the non-surgical group, only 12 (7.7%) were seizure-free Table 2 Comparison of video-EEG findings of surgical and non-surgical groups by univariate analysis.
Variables
Surgical group n = 71
Non-surgical group n = 214 during the mean follow-up period of 3.3 (range 0.5-5) years. The difference in the rates of seizures outcome between the surgical and non-surgical groups was highly significant (73.2% vs. 7.7%, P < 0.0005).
Postoperative neurological deficits
Temporary deficits that resolved within three months comprised lower limb weakness in one, hemisensory loss in two and language dysfunction in one patient. Three patients developed hemiparesis (one with dysphasia); all of them were ambulant without support at one-year follow-up. Homonymous hemianopia occurred in nine patients (two occipital, one parietal and six resections involving parietal and occipital lobes or parietotemporal regions), but this anticipated deficit did not interfere with their daily functioning. There was no perioperative or postoperative mortality.
Reasons for exclusion from surgery
The reasons for exclusion from surgery are summarized in Table  4 . The major reasons for exclusion from surgery in our patients were normal MRI in 107 (50%), financial constraints with respect to invasive EEG monitoring in 40 (18.7%) and lesion location at or near language or motor cortical areas in 27 (12.6%) patients. Discordant imaging-EEG findings, dual pathology, active psychiatric symptoms despite adequate treatment and epileptic encephalopathy, associated psychogenic nonepileptic seizures and uncertain seizure-related disability were other reasons for exclusion from surgery. Eleven patients (5.1%) opted for continued medical treatment despite optimal surgical candidacy.
Discussion
In India, patients and their families will have to bear the cost of presurgical evaluation and epilepsy surgery. Although the total direct cost in resource-poor countries amounts to a small fraction of the cost incurred in resource-rich countries, this expenditure is still beyond the reach of majority of people. Therefore, to become cost-effective, it will be necessary for epilepsy surgery centers in resource-poor counties to achieve excellent results by selecting candidates who are destined to have a seizure-free outcome.
Selection of patients with AED-resistant epilepsies that originate outside of the temporal lobe for resective surgery poses one of the most challenging problems in the field of epilepsy surgery, especially in resource-poor countries because of the limited availability of presurgical diagnostic facilities. The correct surgical decision-making is also greatly influenced by the cumulative experience of the center and the ability of the epilepsy surgery team members to pragmatically approach each patient on an individual basis. During the study period, out of 285 patients with extratemporal focal epilepsies, who underwent presurgical evaluation in our epilepsy center in southern India, only 25% of them could be selected for resective surgery and the remaining 75% were excluded from surgery. The difference in the rates of seizure outcome between the surgical and non-surgical groups was highly significant (73.2% vs. 7.7%, P < 0.0005), thereby suggesting that extratemporal resective epilepsy surgery in a well-selected group of patients can be very effective compared to no surgery. Only 3 (4.2%) of our patients developed unanticipated permanent neurological deficits following surgery that did not interfere with their daily functioning.
To the best of our knowledge, there is only one study that has systematically audited the epilepsy surgery selection/exclusion process. In this study (which included patients with both temporal and extratemporal epilepsies) from the Department of Epileptology, University of Bonn, Bonn, Germany, out of 1192 patients who had presurgical evaluation during January 2000 through December 2006, while 768 (64.2%) were selected for surgery, 427 (35.8%) were excluded from surgery. 21 While 73% of patients with a demonstrable lesion in the MRI underwent surgery, only 15% of MRI-negative patients underwent surgery. In the Bonn series, 21 among patients who had a follow-up of more than one year, while 50% of the surgical group was seizure-free, only 10% of those of the nonsurgical group had a seizure-free outcome. The seizure-free outcomes following surgery were 66% in the MRI-positive group and 38% in the MRI-negative group. 21 A comparison between the Bonn series 21 and ours reveal that while proportionately far more PET -positron emission tomography; SPECT -single photon emission computed tomography.
patients can be selected for surgery in a resource-rich country, in both resource-rich and resource-poor countries, an MRI-demonstrable lesion largely dictates not only the selection for surgery but also the post-operative seizure outcome. Although the patient population of the two series is not strictly comparable, a better seizure-free outcome in our series might be ascribed to our practice of limiting surgery to patients who were destined to have an excellent outcome who could be selected by locally available technology and expertise without compromising patient safety. A lesion identified on MRI has been shown consistently to be associated with a favorable postoperative outcome. 1 In a recent meta-analysis, the odds for seizure-free postoperative outcome were three-fold higher in patients with extratemporal epilepsies with lesions compared to those without a lesion. 22 In the current study, while all the patients in the surgical group had a lesion on 1.5 T MRI performed conforming to a well-defined protocol, 107 out of 122 (87.7%) patients with a normal MRI were excluded from surgery. This occurred despite the use of various newer MRI techniques such as 3D FLAIR, susceptibility weighted imaging, surface coil imaging, and 3 T MRI in selected patients. In seven of our patients, despite optimum electro-clinical data suggesting either a lobar localization or hemispheric lateralization, absence of a discernible MRI lesion made it difficult to proceed with surgery. In five of them, SPECT and/or PET were undertaken, but these diagnostic modalities did not yield information sufficient enough to proceed with surgery or for planning invasive monitoring. In a recent critical evaluation of the role of SPECT in presurgical evaluation from our epilepsy center, we found that SPECT influenced the surgical decision making in only 12% of extratemporal epilepsy surgery patients compared to 45% of temporal lobe epilepsy surgery patients. 23 Despite having a well-circumscribed lesion, 27 (12.6%) of our patients could not be selected for surgery due to the proximity of the lesion to eloquent cortical areas. Similarly, 25 (11.7%) patients with multiple MRI-identified lesions were excluded from surgery because of our inability to localize the epileptogenic zone in relation to a single lesion. In 40 (18.7%) patients with electro-clinical data discordant to the MRI identified lesion, we could not proceed further because of their inability to afford invasive monitoring. Thus, in a resource-poor country scenario, in the absence of a well-circumscribed lesion on 1.5 T MRI, there is very little chance for successful extratemporal resective epilepsy surgery. Although additional MRI sequences and 3 T MRI might enhance the detection rate of lesions that are not evident on 1.5 T MRI, lesions thus identified are seldom circumscribed enough to define the extent of surgical resection. In a recent report of 218 patients with extratemporal lesional epilepsies from Bethel Epilepsy Center, Bielefeld, Germany, on multivariate analysis, only the well-circumscribed nature of the lesions on MRI predicted a favorable postoperative outcome.
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In addition to an MRI identified lesion, are there other attributes that further refine the surgical selection process? In a previous study from our center on patients with AED-resistant extratemporal epilepsies, all with an MRI identified lesion, among the variables that did not figure in the surgical selection process, preoperative secondary generalized seizures and frontal lobe resection were associated with less favorable postoperative seizure outcome. 2 In a mutlicenter prospective observational study of resective epilepsy surgeries (temporal and extratemporal combined), Spencer et al. 24 observed that a lack of preoperative secondary generalized seizures was the only attribute that predicted postoperative seizure-free outcome. In another study of neocortical (temporal and extratemporal) epilepsies, Yun et al. 25 identified focal cortical dysplasia as a predictor of unfavorable postoperative seizure outcome by univariate analysis, but this variable did not retain its predictive status on multivariate analysis. In the present study, while clustering of seizures and presence of preoperative neurological deficit favored surgical selection, the presence of preoperative secondary generalized seizures and discordant interictal epileptiform abnormalities were associated with exclusion from surgery. Although the relationship between seizure clustering and selection for surgery defies a satisfactory explanation, patients with tendency for seizures to cluster might get preferentially recruited for surgery because of the high seizure burden, need for rescue medication and repeated hospitalizations. Similarly, it is easier to make decision in favor of surgery in patients with preexisting fixed neurological deficits, compared to those in whom such deficits are likely to be produced by surgery.
The discrepancy between number of male and female patients in our series (193:92) is striking, which is probably related to ascertainment and referral biases. In India, women with epilepsy and their parents often conceal the history of epilepsy and are reluctant to come forward for presurgical evaluation and surgery because of the social stigma associated with this disease and its treatment. 26, 27 As can be inferred from Table 1 , the gender distribution between the surgical and non-surgical groups did not significantly differ indicating that men did not get preferentially selected for surgery compared to women. We wish to acknowledge the following limitations of our study. Although we utilized a prospectively gathered data for this study, the analysis is retrospective. Prospective multicenter studies will be necessary to determine if and how the presurgical evaluation protocol and surgical selection influence postoperative outcome. Although the presurgical evaluation protocol used at our center had remained more or less the same during the study period, later patients had the privilege of being subjected to newer MRI techniques, SPECT and PET. However, as mentioned above, since only very few of our patients underwent these investigations, we feel that they did not significantly influence our selection process. Just over a quarter of our patients in the non-surgical group were lost during follow-up. However, all the operated patients were available for follow-up for a mean period of nearly three years on whom we based seizure outcome.
In a survey conducted in 2006, epilepsy surgery was found to be available in only 13% of resource-poor countries when compared to 66% of resource-rich countries. 28 It is estimated that in India, with over one billion people, there will be at least 500,000 potential candidates for epilepsy surgery, but no more than 300 epilepsy surgeries are currently being undertaken per year in this country as a whole. 15 The enormous surgical treatment gap in resource-poor countries can only be minimized by developing many more cost effective epilepsy surgery programs in these countries. A serious surgical treatment gap exists in resource-rich countries as well, where too few people receive surgical treatment, and often too late, especially among the underprivileged sections of the society. 29 Thus, the mean duration from epilepsy onset to surgery of 12 years in our study is not different from the delay of 16 years 11 and 11 years 30 reported in two recent extratemporal epilepsy surgery series from Germany and USA, respectively. The Atlas of Epilepsy Care, which was published in 2005 jointly by the World Health Organization, International League Against Epilepsy and International Bureau for Epilepsy, concluded that ''when it comes to epilepsy care, most countries are developing countries''. 31 The aptness of this statement is nowhere more evident than in the case of epilepsy surgery in general and extratemporal epilepsy surgery in particular.
Conclusions
In order to be cost-effective, epilepsy surgery centers in resource-poor countries will have to achieve excellent results by selecting patients using locally available limited technology and expertise, without compromising patient safety. The results of our study illustrate that this objective can be achieved by selecting patients with well-circumscribed lesions not adjoining eloquent cortical areas on 1.5 T MRI. In such patients, concordant EEG findings and absence of preoperative secondary generalized seizures reinforce the selection. The enormous surgical treatment gap that exists in resource-poor counties can be minimized only by developing many more cost-effective epilepsy surgery programs. We believe that the information provided through studies like ours will help epilepsy surgery centers in resource-poor countries to develop presurgical evaluation and surgical selection strategies for extratemporal epilepsy surgery candidates based on locally available and affordable facilities.
